Skip to main content

Table 1 Basic characteristics of the subject

From: The comprehensive study on the role of POSTN in fetal congenital heart disease and clinical applications

 

CHD group

Control group

P value

Elisa validation sets (n = 160)

80

80

 

Maternal age (Year)

30.63 ± 5.3

31.86 ± 6.73

0.897

Gestational age (week)

22.664 ± 2.637

21.116 ± 2.601

0.002

NT (cm)

0.152 ± 0.071

0.172 ± 0.069

0.072

NIPT/Down's screening

  

0.741

Low-risk

79

67

–

High-risk

1

13

–

  1. NT, fetal nuchal transparent zone; NIPT, non-invasive prenatal genetic testing. P < 0.05 showed statistical differences
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us